(Q40616325)

22 September 2017

1 reference

title

Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease (English)

1 reference

22 September 2017

0 references

Greig NH

1

1 reference

22 September 2017

Pei XF

2

1 reference

22 September 2017

Soncrant TT

3

1 reference

22 September 2017

Ingram DK

4

1 reference

22 September 2017

Brossi A

5

1 reference

22 September 2017

1 January 1995

1 reference

Medicinal Research Reviews

22 September 2017

1 reference

22 September 2017

15

1 reference

22 September 2017

1

1 reference

22 September 2017

3-31

1 reference

Comparison of butyrylcholinesterase and acetylcholinesterase

22 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150103

Human memory and the cholinergic system. A relationship to aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150103

Biological and neuropsychological characterization of physostigmine responders and nonresponders in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150103

The effect of long-term physostigmine administration in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150103

Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150103

Long-term administration of oral physostigmine in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150103

Physostigmine and N8-norphysostigmine, insecticidal compounds, from Streptomyces sp.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB1961.50.523

Identifiers

DOI

10.1002/MED.2610150103

1 reference

22 September 2017

1 reference